Ex parte FUKUYAMA et al. - Page 5




          Appeal No. 1999-0008                                                        
          Application No. 08/625,834                                                  


          then shifts to the applicant to overcome the prima facie case               
          with argument and/or evidence.  Obviousness, is then determined             
          on the basis of the evidence as a whole and the relative                    
          persuasiveness of the arguments.  See In re Oetiker, 977 F.2d               
          1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In re Hedges,            
          783 F.2d 1038, 1039, 228 USPQ 685, 686 (Fed. Cir. 1986); In re              
          Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788 (Fed. Cir.                 
          1984); and In re Rinehart, 531 F.2d 1048, 1052, 189 USPQ 143,               
          147 (CCPA 1976).  We are further guided by the precedence of our            
          reviewing court that the limitations from the disclosure are not            
          to be imported into the claims.  In re Lundberg, 244 F.2d 543,              
          113 USPQ 530 (CCPA 1957); In re Queener, 796 F.2d 461, 230 USPQ             
          438 (Fed. Cir. 1986).  We also note that the arguments not made             
          separately for any individual claim or claims are considered                
          waived.  See 37 CFR § 1.192(a) and (c).  In re Baxter Travenol              
          Labs., 952 F.2d 388, 391, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991)             
          (“It is not the function of this court to examine the claims in             
          greater detail than argued by an appellant, looking for                     
          nonobviousness distinctions over the prior art.”); In re                    
          Wiechert, 370 F.2d 927, 936, 152 USPQ 247, 254 (CCPA 1967)(“This            
          court has uniformly followed the sound rule that an issue raised            
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007